These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 596461)
1. Glucagon inhibition of hepatic arterial responses to hepatic nerve stimulation. Richardson PD; Withrington PG Am J Physiol; 1977 Dec; 233(6):H647-54. PubMed ID: 596461 [TBL] [Abstract][Full Text] [Related]
2. The inhibition by glucagon of the vasoconstrictor actions of noradrenaline, angiotensin and vasopressin on the hepatic arterial vascular bed of the dog. Richardson PD; Withrington PG Br J Pharmacol; 1976 May; 57(1):93-102. PubMed ID: 1276544 [TBL] [Abstract][Full Text] [Related]
3. The effects of intraportal infusions of glucagon on the hepatic arterial and portal venous vascular beds of the dog: inhibition of hepatic arterial vasoconstrictor reponses to noradrenaline. Richardson PD; Withrington PG Pflugers Arch; 1978 Dec; 378(2):135-40. PubMed ID: 569834 [TBL] [Abstract][Full Text] [Related]
4. The effects of glucagon, secretin, pancreozymin and pentagastrin on the hepatic arterial vascular bed of the dog. Richardson PD; Withrington PG Br J Pharmacol; 1977 Jan; 59(1):147-56. PubMed ID: 836995 [TBL] [Abstract][Full Text] [Related]
5. Effects of intraportal glucagon on responses of simultaneously perfused hepatic vascular beds of the dog to periarterial nerve stimulation [proceedings]. Richardson PD; Withrington PG J Physiol; 1978 Nov; 284():102P-103P. PubMed ID: 731450 [No Abstract] [Full Text] [Related]
6. Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog. Richardson PD; Withrington PG J Physiol; 1978 Sep; 282():451-70. PubMed ID: 722550 [TBL] [Abstract][Full Text] [Related]
7. The vasodilator actions of isoprenaline, histamine, prostaglandin E2, glucagon and secretin on the hepatic arterial vascular bed of the dog. Richardson PD; Withrington PG Br J Pharmacol; 1976 Aug; 57(4):581-8. PubMed ID: 963344 [TBL] [Abstract][Full Text] [Related]
8. The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline. Richardson PD; Withrington PG Br J Pharmacol; 1977 Jun; 60(2):239-49. PubMed ID: 195661 [TBL] [Abstract][Full Text] [Related]
9. The effect of glucagon on vasoconstriction and vascular escape from nerve- and norepinephrine-induced constriction of the hepatic artery of the cat. D'Almeida MS; Lautt WW Can J Physiol Pharmacol; 1989 Nov; 67(11):1418-25. PubMed ID: 2627682 [TBL] [Abstract][Full Text] [Related]
10. Responses of the hepatic arterial and portal venous vascular beds of the dog to intra-arterial infusions of noradrenaline and adrenaline: inhibition of the hepatic arterial vasoconstrictor responses by intraportal infusions of glucagon [proceedings]. Richardson PD; Withrington PG Br J Pharmacol; 1979 May; 66(1):82P. PubMed ID: 556185 [No Abstract] [Full Text] [Related]
11. Adenosine modulation of hepatic arterial but not portal venous constriction induced by sympathetic nerves, norepinephrine, angiotensin, and vasopressin in the cat. Lautt WW; Legare DJ Can J Physiol Pharmacol; 1986 Apr; 64(4):449-54. PubMed ID: 3730928 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of hepatic venous resistance responses using index of contractility. Lautt WW; Legare DJ Am J Physiol; 1992 Mar; 262(3 Pt 1):G510-6. PubMed ID: 1550239 [TBL] [Abstract][Full Text] [Related]
13. [Regulation of liver metabolism and hemodynamics by the hepatic nerves]. Jungermann K Z Gastroenterol; 1987 Apr; 25 Suppl 1():44-54. PubMed ID: 3590903 [TBL] [Abstract][Full Text] [Related]
14. Sympathetic drive to liver and nonhepatic splanchnic tissue during prolonged exercise is increased in diabetes. Coker RH; Krishna MG; Zinker BA; Allen EJ; Lacy DB; Wasserman DH Metabolism; 1997 Nov; 46(11):1327-32. PubMed ID: 9361694 [TBL] [Abstract][Full Text] [Related]
15. Differential action of hepatic sympathetic neuropeptides: metabolic action of galanin, vascular action of NPY. Mundinger TO; Taborsky GJ Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E390-7. PubMed ID: 10710492 [TBL] [Abstract][Full Text] [Related]
16. Modification of the vasomotor actions of methysergide in the femoral arterial bed of the anaesthetized dog by changes in sympathetic nerve activity. Feniuk W; Humphrey PP; Watts AD J Auton Pharmacol; 1981 Mar; 1(2):127-32. PubMed ID: 6121808 [TBL] [Abstract][Full Text] [Related]
17. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1). Effects on basal release of insulin and glucagon. Ahrén B; Veith RC; Taborsky GJ Endocrinology; 1987 Jul; 121(1):323-31. PubMed ID: 3297643 [TBL] [Abstract][Full Text] [Related]
18. Blood mobilization from the liver of the anaesthetized dog. Noble BJ; Drinkhill MJ; Myers DS; Hainsworth R Exp Physiol; 1998 Jul; 83(4):513-22. PubMed ID: 9717073 [TBL] [Abstract][Full Text] [Related]
19. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide. Ahrén B; Veith RC; Paquette TL; Taborsky GJ Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175 [TBL] [Abstract][Full Text] [Related]
20. Regulation of liver metabolism by the hepatic nerves. Jungermann K; Gardemann A; Beuers U; Ballé C; Sannemann J; Beckh K; Hartmann H Adv Enzyme Regul; 1987; 26():63-88. PubMed ID: 3673710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]